Stock listing
BOATS:LPCN Lipocine Inc. Stock
US listing (BOATS) of Lipocine Inc. · home listing NASDAQ:LPCN
Follow Lipocine Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:LPCN
$1.44 USD -0.08 (-5.3%)
Close on Oct 30, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:LPCN
- Day range
- $1.42 – $1.50 USDOct 30, 2026
- Volume
- 111,917 sharesOct 30, 2026
- Market cap
- $11.87M USDAt the close on Oct 30, 2026 · price × 8.24M shares outstanding
- 52-week range
- $1.40 – $12.37 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $3.79M USDMedian day 40,196 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:LPCN · Home | $1.44 USD | -0.08 (-5.3%) | 111,917 | $1.50 | $1.50 | $1.42 | $1.52 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:LPCN · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $1.44 | -0.08 | -5.3% | $1.50 | $1.50 | $1.42 | 111,917 | |
| $1.52 | +0.01 | +0.7% | $1.51 | $1.559 | $1.50 | 139,013 | |
| $1.51 | +0.05 | +3.4% | $1.46 | $1.54 | $1.46 | 193,298 | |
| $1.46 | +0.01 | +0.7% | $1.49 | $1.49 | $1.425 | 127,603 | |
| $1.45 | +0.01 | +0.7% | $1.44 | $1.45 | $1.40 | 108,521 | |
| $1.44 | -0.02 | -1.4% | $1.42 | $1.48 | $1.41 | 218,100 | |
| $1.46 | -0.14 | -8.8% | $1.56 | $1.60 | $1.43 | 354,800 | |
| $1.60 | -0.02 | -1.2% | $1.59 | $1.64 | $1.581 | 159,600 | |
| $1.62 | +0.09 | +5.9% | $1.54 | $1.66 | $1.537 | 244,700 | |
| $1.53 | -0.03 | -1.9% | $1.51 | $1.57 | $1.40 | 323,400 | |
| $1.56 | -0.12 | -7.1% | $1.66 | $1.68 | $1.48 | 405,900 | |
| $1.68 | -0.01 | -0.6% | $1.64 | $1.69 | $1.59 | 264,400 | |
| $1.69 | +0.07 | +4.3% | $1.69 | $1.71 | $1.60 | 374,300 | |
| $1.62 | -0.04 | -2.4% | $1.64 | $1.74 | $1.61 | 500,400 | |
| $1.66 | -0.06 | -3.5% | $1.705 | $1.77 | $1.59 | 877,600 | |
| $1.72 | -0.21 | -10.9% | $1.89 | $1.90 | $1.72 | 1,056,700 | |
| $1.93 | -0.27 | -12.3% | $2.05 | $2.05 | $1.89 | 2,322,300 | |
| $2.20 | +0.10 | +4.8% | $2.95 | $3.15 | $2.07 | 105,835,900 | |
| $2.10 | +0.03 | +1.4% | $2.08 | $2.10 | $2.07 | 12,800 | |
| $2.07 | +0.02 | +1.0% | $2.07 | $2.135 | $2.07 | 19,800 | |
| $2.05 | -0.02 | -1.0% | $2.08 | $2.13 | $2.05 | 38,900 | |
| $2.07 | -0.13 | -5.9% | $2.19 | $2.19 | $2.07 | 71,200 | |
| $2.20 | +0.04 | +1.9% | $2.14 | $2.25 | $2.08 | 31,400 | |
| $2.16 | +0.07 | +3.3% | $2.09 | $2.21 | $2.09 | 24,300 | |
| $2.09 | -0.01 | -0.5% | $2.07 | $2.21 | $2.06 | 34,400 | |
| $2.10 | +0.01 | +0.5% | $2.12 | $2.182 | $2.06 | 32,800 | |
| $2.09 | -0.03 | -1.4% | $2.10 | $2.178 | $2.08 | 32,600 | |
| $2.12 | -0.04 | -1.9% | $2.15 | $2.18 | $2.12 | 90,900 | |
| $2.16 | -0.08 | -3.6% | $2.13 | $2.22 | $2.12 | 64,300 | |
| $2.24 | +0.03 | +1.4% | $2.19 | $2.25 | $2.18 | 16,700 | |
| $2.21 | -0.01 | -0.5% | $2.20 | $2.25 | $2.12 | 48,500 | |
| $2.22 | +0.06 | +2.8% | $2.16 | $2.22 | $2.10 | 43,900 | |
| $2.16 | -0.025 | -1.1% | $2.23 | $2.235 | $2.15 | 64,000 | |
| $2.185 | -0.035 | -1.6% | $2.20 | $2.24 | $2.15 | 50,500 | |
| $2.22 | -0.05 | -2.2% | $2.20 | $2.27 | $2.15 | 27,300 | |
| $2.27 | +0.02 | +0.9% | $2.29 | $2.30 | $2.25 | 10,400 | |
| $2.25 | 0.00 | 0.0% | $2.315 | $2.345 | $2.25 | 9,400 | |
| $2.25 | -0.11 | -4.7% | $2.34 | $2.353 | $2.25 | 4,800 | |
| $2.36 | -0.09 | -3.7% | $2.39 | $2.40 | $2.345 | 21,100 | |
| $2.45 | +0.03 | +1.2% | $2.421 | $2.48 | $2.361 | 23,100 | |
| $2.42 | +0.065 | +2.8% | $2.41 | $2.50 | $2.32 | 26,500 | |
| $2.355 | +0.055 | +2.4% | $2.22 | $2.39 | $2.22 | 34,200 | |
| $2.30 | +0.06 | +2.7% | $2.19 | $2.30 | $2.183 | 10,000 | |
| $2.24 | +0.07 | +3.2% | $2.14 | $2.29 | $2.14 | 27,500 | |
| $2.17 | -0.06 | -2.7% | $2.23 | $2.23 | $2.13 | 19,500 | |
| $2.23 | +0.08 | +3.7% | $2.17 | $2.30 | $2.17 | 41,500 | |
| $2.15 | 0.00 | 0.0% | $2.15 | $2.29 | $2.15 | 106,000 | |
| $2.15 | +0.09 | +4.4% | $2.08 | $2.16 | $2.07 | 11,800 | |
| $2.06 | -0.03 | -1.4% | $2.07 | $2.10 | $2.05 | 26,700 | |
| $2.09 | 0.00 | 0.0% | $2.11 | $2.11 | $2.06 | 18,200 | |
| $2.09 | +0.04 | +2.0% | $2.05 | $2.135 | $2.05 | 35,200 | |
| $2.05 | +0.01 | +0.5% | $2.105 | $2.115 | $2.05 | 24,900 | |
| $2.04 | -0.01 | -0.5% | $2.08 | $2.131 | $2.04 | 29,100 | |
| $2.05 | -0.06 | -2.8% | $2.09 | $2.13 | $2.04 | 30,300 | |
| $2.11 | +0.05 | +2.4% | $2.10 | $2.18 | $2.07 | 31,400 | |
| $2.06 | 0.00 | 0.0% | $2.07 | $2.224 | $2.04 | 23,700 | |
| $2.06 | -0.03 | -1.4% | $2.11 | $2.13 | $2.02 | 49,000 | |
| $2.09 | -0.01 | -0.5% | $2.10 | $2.16 | $2.09 | 13,317 | |
| $2.10 | -0.03 | -1.4% | $2.16 | $2.21 | $2.10 | 41,492 | |
| $2.13 | 0.00 | 0.0% | $2.26 | $2.26 | $2.12 | 33,900 | |
| $2.13 | -0.04 | -1.8% | $2.14 | $2.18 | $2.08 | 37,000 | |
| $2.17 | +0.04 | +1.9% | $2.19 | $2.261 | $2.15 | 56,200 | |
| $2.13 | +0.02 | +0.9% | $2.13 | $2.22 | $2.06 | 131,400 | |
| $2.11 | -0.01 | -0.5% | $2.239 | $2.239 | $2.03 | 91,300 | |
| $2.12 | +0.01 | +0.5% | $2.16 | $2.16 | $2.10 | 29,400 | |
| $2.11 | +0.04 | +1.9% | $2.05 | $2.20 | $2.05 | 58,300 |
- Ticker
- BOATS:LPCN
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- BOATS
- Currency
- USD
What changed lately
Latest news release · Oct 7, 2026
Lipocine Announces Health Canada Approval of TLANDO® for Testosterone Replacement Therapy
Latest deck · October 2026
Investor Presentation (October 2026)
Investor deck · 42 slides
Latest news
Lipocine Announces Health Canada Approval of TLANDO® for Testosterone Replacement Therapy
Oct 7, 2026
Closed $2.20 (+4.8%) on Oct 7, 2026
Lipocine Announces Initiation of BLOOM Phase 3 Study of LPCN 1154 for Postpartum Depression
Sep 14, 2026
Closed $2.22 (-2.2%) on Sep 14, 2026
Lipocine to Present at the H.C. Wainwright 28th Annual Global Investment Conference
Sep 10, 2026
Closed $2.25 (0.0%) on Sep 10, 2026
Lipocine Appoints Michael J. Grissinger to Board of Directors
Aug 3, 2026
Closed $2.11 (-0.5%) on Aug 3, 2026
Lipocine Inc. to Host Virtual KOL Event Highlighting Unmet Needs in Postpartum Depression and the Clinical Profile of LPCN 1154
Jun 4, 2026
Closed $2.21 (+0.9%) on Jun 4, 2026
Lipocine Announces LPCN 1154 Phase 3 Data Accepted for Oral Presentation at 2026 ASCP Annual Meeting
May 19, 2026
Closed $2.20 (-0.5%) on May 19, 2026
Lipocine to Present at A.G.P.'s Annual Virtual Healthcare Company Showcase
May 18, 2026
Closed $2.21 (-2.2%) on May 18, 2026
Lipocine Announces Financial Results for the First Quarter Ended March 31, 2026
May 7, 2026
Closed $2.37 (-0.8%) on May 8, 2026
Lipocine Reports Topline Safety and Efficacy Results for LPCN 1154 in Patients with Postpartum Depression
Apr 2, 2026
Closed $2.05 (-77.8%) on Apr 2, 2026
Lipocine Announces Financial Results for the Full Year Ended December 31, 2025
Mar 10, 2026
Closed $8.11 (+2.9%) on Mar 10, 2026
Decks
Investor Presentation (October 2026)
Investor deck · 42 slides · October 2026
H.C. Wainwright 28th Annual Global Investment Conference 2026
Conference · 22 slides · September 2026
Technical Presentation (June 2026)
Technical · 46 slides · Jun 12, 2026
Investor Presentation (May 2026)
Investor deck · 58 slides · May 7, 2026
Lipocine Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 17 in the last 12 months · 136 in all · newest Oct 7, 2026 · oldest 2019
- Decks
- 153 decks · latest October 2026
Where Lipocine Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:LPCN · Home listing | NASDAQ | United States | USD |
| BOATS:LPCN · This page | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Lipocine Inc.